# Fludeoxyglucose F 18

NDC: 75913-647
Generic name: Fludeoxyglucose F 18
Labeler / Manufacturer: Washington University School of Medicine
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20110102

FDA application: ANDA203935

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 300 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75913-647"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75913-647
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae48ac7d-1c50-4b32-a3e6-c2e5de5b63ed